Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Cardiovascular Drugs and Therapy
|
October 24, 2001
Factors determining spontaneous ventricular defibrillation
N Tribulova, M Manoach
Circulation
|
April 27, 1999
Is the antiarrhythmic effects of PA related to wavelength?
N Tribulova, M Manoach
Experimental and Clinical Cardiology
|
April 30, 2010
Factors determining spontaneous ventricular defibrillation
N Tribulova, M Manoach
Cardiovascular Drug Reviews
|
August 3, 2001
Sotalol: the mechanism of its antiarrhythmic-defibrillating effect
M Manoach, N Tribulova
Journal of Submicroscopic Cytology and Pathology
|
April 1, 1993
Influencing of calcium paradox by membrane stabilizing agents: the role of sarcolemma and intercalated disc
N Tribulova, J Slezak, T Ravingerova
Journal of Basic and Clinical Physiology and Pharmacology
|
October 1, 1993
Reperfusion-induced arrhythmias in isolated rat heart: an index of cellular damage or viability of cardiomyocytes?
N Tribulova, T Ravingerova, J Slezak
Heart and Vessels
|
January 1, 1996
The protective effect of D-sotalol against hypoxia-induced myocardial uncoupling
M Manoach, N Tribulova, I Imanaga
Life Sciences
|
July 31, 2003
Modulation of intracellular Ca(2+) concentration by tedisamil, a class III antiarrhythmic agent, in isolated heart preparation
S Seki, N Tribulova, M Manoach, et al.
European Heart Journal
|
December 1, 1991
Features of the (Na, K)-ATPase of cardiac sarcolemma with particular reference to myocardial ischaemia
N Vrbjar, J Slezak, A Ziegelhoffer, et al.
Journal of Submicroscopic Cytology and Pathology
|
June 11, 1999
Attenuation of Ca paradox injury in guinea pig heart by K+ channel blocker, d-sotalol
N Tribulova, I Sosner, D Varon, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Cardiovascular Drugs and Therapy
|
October 24, 2001
Factors determining spontaneous ventricular defibrillation
N Tribulova, M Manoach
Circulation
|
April 27, 1999
Is the antiarrhythmic effects of PA related to wavelength?
N Tribulova, M Manoach
Experimental and Clinical Cardiology
|
April 30, 2010
Factors determining spontaneous ventricular defibrillation
N Tribulova, M Manoach
Cardiovascular Drug Reviews
|
August 3, 2001
Sotalol: the mechanism of its antiarrhythmic-defibrillating effect
M Manoach, N Tribulova
Journal of Submicroscopic Cytology and Pathology
|
April 1, 1993
Influencing of calcium paradox by membrane stabilizing agents: the role of sarcolemma and intercalated disc
N Tribulova, J Slezak, T Ravingerova
Journal of Basic and Clinical Physiology and Pharmacology
|
October 1, 1993
Reperfusion-induced arrhythmias in isolated rat heart: an index of cellular damage or viability of cardiomyocytes?
N Tribulova, T Ravingerova, J Slezak
Heart and Vessels
|
January 1, 1996
The protective effect of D-sotalol against hypoxia-induced myocardial uncoupling
M Manoach, N Tribulova, I Imanaga
Life Sciences
|
July 31, 2003
Modulation of intracellular Ca(2+) concentration by tedisamil, a class III antiarrhythmic agent, in isolated heart preparation
S Seki, N Tribulova, M Manoach, et al.
European Heart Journal
|
December 1, 1991
Features of the (Na, K)-ATPase of cardiac sarcolemma with particular reference to myocardial ischaemia
N Vrbjar, J Slezak, A Ziegelhoffer, et al.
Journal of Submicroscopic Cytology and Pathology
|
June 11, 1999
Attenuation of Ca paradox injury in guinea pig heart by K+ channel blocker, d-sotalol
N Tribulova, I Sosner, D Varon, et al.
Page
of 4